Pacer Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$209M Sell
2,450,460
-148,594
-6% -$13.2M 0.59% 41
2025
Q4
$205M Sell
2,599,054
-97,993
-4% -$7.68M 0.52% 46
2025
Q3
$216M Buy
2,697,047
+2,611,485
+3,052% +$223M 0.54% 44
2025
Q2
$7.78M Buy
85,562
+27,307
+47% +$2.49M 0.02% 563
2025
Q1
$5.46M Sell
58,255
-31,595
-35% -$2.83M 0.01% 608
2024
Q4
$8.17M Sell
89,850
-21,422
-19% -$2.04M 0.02% 501
2024
Q3
$11.6M Buy
111,272
+17,623
+19% +$1.8M 0.02% 436
2024
Q2
$9.09M Sell
93,649
-597
-0.6% -$55.1K 0.02% 456
2024
Q1
$8.49M Sell
94,246
-22,998
-20% -$1.95M 0.02% 462
2023
Q4
$9.35M Buy
117,244
+41,731
+55% +$3.14M 0.03% 418
2023
Q3
$5.37M Buy
75,513
+1,304
+2% +$97.5K 0.02% 455
2023
Q2
$5.72M Buy
74,209
+13,135
+22% +$1.02M 0.02% 506
2023
Q1
$4.59M Sell
61,074
-108,209
-64% -$8.05M 0.02% 558
2022
Q4
$13.3M Buy
169,283
+136,353
+414% +$10.2M 0.07% 229
2022
Q3
$2.31M Sell
32,930
-102,411
-76% -$8.03M 0.02% 421
2022
Q2
$10.8M Buy
135,341
+92,018
+212% +$7.2M 0.08% 210
2022
Q1
$3.29M Sell
43,323
-9,456
-18% -$749K 0.03% 502
2021
Q4
$4.5M Sell
52,779
-47,814
-48% -$3.73M 0.05% 499
2021
Q3
$7.6M Buy
100,593
+23,678
+31% +$1.88M 0.1% 248
2021
Q2
$6.26M Buy
76,915
+30,386
+65% +$2.48M 0.09% 293
2021
Q1
$3.67M Sell
46,529
-6,841
-13% -$536K 0.06% 324
2020
Q4
$4.56M Sell
53,370
-17,279
-24% -$1.43M 0.09% 193
2020
Q3
$5.45M Sell
70,649
-13,638
-16% -$1.04M 0.12% 138
2020
Q2
$6.17M Buy
+84,287
New +$5.99M 0.13% 129
2020
Q1
Sell
-97,989
Closed -$6.75M 746
2019
Q4
$6.75M Sell
97,989
-1,454
-1% -$99.1K 0.3% 53
2019
Q3
$7.31M Buy
99,443
+11,956
+14% +$867K 0.16% 107
2019
Q2
$6.27M Buy
87,487
+4,402
+5% +$312K 0.15% 109
2019
Q1
$5.69M Buy
+83,085
New +$5.37M 0.16% 107
2018
Q4
Sell
-46,771
Closed -$3.13M 634
2018
Q3
$3.13M Buy
46,771
+6,194
+15% +$413K 0.12% 164
2018
Q2
$2.63M Buy
40,577
+6,820
+20% +$446K 0.12% 175
2018
Q1
$2.42M Buy
33,757
+5,445
+19% +$392K 0.13% 151
2017
Q4
$2.14M Buy
28,312
+5,982
+27% +$437K 0.15% 135
2017
Q3
$1.63M Buy
22,330
+2,106
+10% +$152K 0.14% 112
2017
Q2
$1.5M Buy
20,224
+1,566
+8% +$116K 0.15% 109
2017
Q1
$1.37M Buy
18,658
+1,123
+6% +$78.6K 0.17% 85
2016
Q4
$1.15M Buy
17,535
+351
+2% +$24.1K 0.16% 86
2016
Q3
$1.27M Sell
17,184
-102
-0.6% -$7.54K 0.19% 72
2016
Q2
$1.26M Buy
17,286
+1,442
+9% +$103K 0.2% 75
2016
Q1
$1.12M Sell
15,844
-2
-0% -$133 0.25% 78
2015
Q4
$1.06M Buy
+15,846
New +$1.05M 0.25% 80
2013
Q4
$597K Buy
+8,634
New +$553K 0.14% 194

Other funds holding CL

Pacer Advisors's CL Position: Q1 2026 in Review

Pacer Advisors reduced its Colgate-Palmolive (CL) stake by 5.7% in Q1 2026, selling an estimated $13.2M and leaving 2,450,460 shares worth $209M. The position accounts for 0.59% of the portfolio, ranked #41.

Pacer Advisors first reported a position in CL in Q4 2013 and has held it in 41 quarters since. The position peaked at $216M in Q3 2025. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Pacer Advisors held 2,450,460 shares of Colgate-Palmolive worth $209M as of Q1 2026.
  • Pacer Advisors sold 148,594 Colgate-Palmolive shares in Q1 2026, an estimated $13.2M.
  • Colgate-Palmolive made up 0.59% of Pacer Advisors's portfolio in Q1 2026, its #41 holding.
  • Pacer Advisors first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 41 quarters since.
  • Pacer Advisors's Colgate-Palmolive position peaked at $216M in Q3 2025.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.